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Abstract
Introduction—Studies suggest that both affective and cognitive processes are involved in the 
perception of vulnerability to cancer and that affect has an early influence in this assessment of 
risk. We constructed a path model based on a conceptual framework of heuristic reasoning (affect, 
resemblance, and availability) coupled with cognitive processes involved in developing personal 
models of cancer causation.
Methods—From an eligible cohort of 16 700 women in a managed care organization, we 
randomly selected 2524 women at high, elevated, and average risk of ovarian cancer and 
administered a questionnaire to test our model (response rate 76.3%). Path analysis delineated the 
relationships between personal and cognitive characteristics (number of relatives with cancer, age, 
ideas about cancer causation, perceived resemblance to an affected friend or relative, and ovarian 
cancer knowledge) and emotional constructs (closeness to an affected relative or friend, time spent 
processing the cancer experience, and cancer worry) on perceived risk of ovarian cancer.
Results—Our final model fit the data well (root mean square error of approximation (RMSEA) = 
0.028, comparative fit index (CFI) = 0.99, normed fit index (NFI) = 0.98). This final model (1) 
demonstrated the nature and direction of relationships between cognitive characteristics and 
perceived risk; (2) showed that time spent processing the cancer experience was associated with 
cancer worry; and (3) showed that cancer worry moderately influenced perceived risk.
Discussion—Our results highlight the important role that family cancer experience has on 
cancer worry and shows how cancer experience translates into personal risk perceptions. This 
understanding informs the discordance between medical or objective risk assessment and personal 
risk assessment.
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The concept of risk perception has played a key role in models of health behavior, in 
medical and psychological research, and in strategies of informed decision-making and risk 
communication [1]. Despite its importance, risk perception has been described as a 
‘phenomenon in search of an explanation’ [2]. A person’s perception of risk might influence 
decisions about whether to seek screening, undergo preventive surgery, or make behavioral 
changes intended to reduce risk. Yet the literature on risk perception has demonstrated that 
objective, probability-based, numeric risk assessments often are discordant with individuals’ 
perceptions of their own risk, sometimes leading to unnecessary distress, and potentially 
jeopardizing sound medical decision-making. Studies that have focused on genetic 
counseling and hereditary cancers, especially breast cancer, suggest that women 
overestimate their risk for cancer, irrespective of their objective risk as determined by their 
age and family history [3-5]. Furthermore, genetic counseling, which aims to help people 
understand the potential contribution of genetics to disease risk, often has only a limited 
effect on improving the accuracy of perceived risk [4,5] because perceived susceptibility to 
cancer appears to be resistant to change [6].
The lack of agreement between objective and perceived risk can be partially explained by an 
influence of contextual factors on risk perceptions [7], or by limitations in how perceived 
risk is measured [8]. More important is the growing recognition of an affective or emotional 
component of risk judgment in a process typically regarded as cognitive [2,9]. It has been 
suggested that perceived risk is not one concept but rather a construct made up of both 
deliberative or cognitive processing and associative or intuitive processing that might at 
times conflict with one another [10]. Whether emotional constructs such as worry or concern 
operate separately from the more cognitive aspects of risk perception or whether cognitive 
risk judgment and worry have a causal or reciprocal relationship bears further study [11]. 
More work is needed to expand our understanding of how emotional processes are 
integrated into risk perceptions and decision-making [12].
Judgment and decision-making theory provides guidance about how people use both rational 
and emotionally-based heuristics to develop judgments and facilitate decision making in the 
face of uncertainty or complexity [13,14]. Among the heuristics that have been used to 
describe how information is incorporated into an assessment of perceived cancer risk are the 
affect heuristic, which acknowledges the contribution of feelings in assessing a threat; the 
representativeness heuristic where judgment about an event is based on perceived similarity 
or dissimilarity to an affected person; and the availability heuristic, which poses that more 
salient, familiar, and imaginable events are more easily recalled and judged as probable 
[15,16].
A woman’s experience with cancer illness or death among relatives and friends as well as 
her knowledge about the hereditary nature of the cancer can evoke heuristic processing 
when asked to assess her personal vulnerability to cancer. The more salient a woman’s 
experience with cancer, in terms of the emotional intensity of the relationship with an 
affected relative or friend, the more likely it is that she will perceive her own risk of cancer 
to be high, irrespective of her objective risk. [17,18]. The intensity of a direct cancer 
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experience may be affected by factors such as strength of the relationship, observation of 
negative change in the family member or friend, physical and psychological resemblance to 
the affected relative or friend, and the ability to talk about the experience with the affected 
person or with others [19].
The aim of this study was to explore the cognitive and emotional antecedents of perceived 
risk of ovarian cancer and to elucidate the relationship between cancer worry and perceived 
risk of ovarian cancer. We propose that the heuristics of availability, affect (worry), and 
representativeness play key roles in developing personal models of cancer causation and 
vulnerability. Based on a conceptual framework developed by Walter and colleagues 
[20,21], we tested a model that included (1) the construct of salience, which is strongly 
influenced by personal experiences of cancer among relatives and friends; (2) knowledge of 
disease causation and inheritance that inform mental models of cancer; and (3) cognitive and 
emotional processing of the cancer experience into a perceived vulnerability to cancer 
(Figure 1 conceptual model).
The affective components of this model include living through the cancer experience of the 
affected person, emotional closeness to the affected person, bereavement, and anxiety and 
cancer worry. The cognitive component of this model includes the direct inputs into 
processing a mental model of cancer such as ideas about cancer causation, age, knowledge 
about ovarian cancer, number of relatives with cancer, and resemblance to the affected 
friend or relative. We believe that processing the emotional components of the cancer 
experience along with assessing cancer causes together influence perceived vulnerability to 
cancer.
Finally, because much of the research on risk perception and screening has been conducted 
in clinical settings with women at high risk [4,22], we sought to expand the examination of 




The data for this study were collected as part of a cross-sectional baseline survey on 
perceived risk of ovarian cancer and cancer screening among women at high, elevated, and 
average risk of ovarian cancer. The study was conducted among women in the Henry Ford 
Health System (HFHS) in Detroit, Michigan, which serves the primary and specialty health 
care needs of many residents in southeastern Michigan. Details on the sampling strategy and 
implementation of this survey have been previously published [23].
Briefly, those eligible to participate were women 30 years or older who had not been 
diagnosed with ovarian cancer and who reported not having had both of their ovaries 
removed. Participants also had to speak and understand English and respond to survey 
questions in English. We used a computer-assisted telephone interviewing (CATI) system to 
contact women, provide them with basic information about the research study, and then 
administer a brief eligibility screener. Immediately after administering the eligibility 
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screening questions, the programmed CATI system randomly selected respondents for 
participation in a full interview. Out of an initial list of 55 887 women enrolled in the HFHS 
system, 20 483 were screened for eligibility (36.7%), and 16 720 were considered eligible 
(81.6%). Out of 3307 women who were randomly selected for a computer-assisted 
telephone interview, 2524 consented and completed the 35-min interview (response rate 
76.3%). The survey was conducted from January 16, 2008 to December 12, 2008. 
Participants were provided with a $15 gift card upon completion of the interview.
We obtained approval for this study from the Institutional Review Boards of the Centers for 
Disease Control and Prevention and HFHS. Because we were asking respondents potentially 
sensitive information about their personal and family history of cancer, including previous 
receipt of BRCA1/BRCA2 genetic testing and the results of genetic tests, we obtained a 
301(d) Certificate of Confidentiality of the Public Health Service Act for this study. We 
consented all respondents before conducting the survey interviews.
Measures
Our survey included original questions as well as previously-used instruments that allowed 
for the collection of valid and reliable data. We also adapted some existing scales to meet 
our specific needs. We selected variables and measures that corresponded to each of the 
components of our conceptual model and tested each of the measures for clarity of wording 
and appropriate response categories through cognitive interviewing methods.
Perceived risk of ovarian cancer—We summed three variables to create a composite 
measure of perceived risk of ovarian cancer. Women were asked whether their 10-year and 
lifetime risks of developing ovarian cancer are much higher, higher, about the same, lower, 
or much lower, than risk in most women their age. These perceived risk measures have been 
used previously in studies and have demonstrated high correlation and stability [24]. We 
also asked respondents if they thought their family history of cancer greatly increases, 
somewhat increases, has no effect on, somewhat decreases, or greatly decreases their risk of 
cancer. The internal consistency estimate of reliability for this scale could be considered 
marginally adequate given only three items (Cronbach’s alpha = 0.67).
Cancer worry—We adapted the Breast Cancer Worry Scale [25] to assess participants’ 
levels of concern about ovarian cancer and the extent to which it affects daily functioning. 
Using the responses of never, rarely, sometimes, a lot, and all the time, participants reported 
how often they have thought about their chances of developing ovarian cancer, how often 
thoughts of getting ovarian cancer have affected their mood, and how often these thoughts 
have affected their ability to perform daily activities. This scale has been used in studies of 
ovarian cancer screening [26]. Responses were summed across the three variables. The 
internal consistency estimate of reliability for the worry measure in this survey was adequate 
(Cronbach’s alpha = 0.76).
Family history of cancer—Participants were asked about breast and ovarian cancers in 
first-degree and second-degree relatives on both the mother’s and father’s side of the family. 
Participants were also asked whether any blood relatives had cancer other than breast or 
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ovarian cancer and the type of cancer. Self-reports of cancer in family members, particularly 
first-degree relatives, have been found to be accurate and reliable [27]. We created two 
variables for analysis: (1) a count of first-degree and second-degree relatives with ovarian 
cancer and (2) a count of all relatives with any cancers.
Anxiety—Anxiety plays an important role in information processing [28]. Our survey 
included The State-Trait Anxiety inventory [29]. This is a well-validated scale that measures 
underlying (trait) and situational (state) anxiety. Participants were asked to respond to a 
series of statements about being generally or currently calm, tense, upset, relaxed, or worried 
using a four-point Likert-type scale (1 = not at all, 2 = somewhat, 3 = moderately, 4 = very 
much). For this study sample, the Cronbach’s alpha values for state and trait anxiety were 
0.78 and 0.79, respectively, demonstrating adequate internal consistency for both subscales.
Cancer experience—We used the Connection to the Experience of Cancer Scale to 
measure the experience of cancer among friends or relatives [19]. Participants were asked to 
identify the relative or friend with cancer to whom they felt the closest and whether that 
person survived cancer. Participants were asked about how much time was spent with the 
friend or relative, how much negative change they observed in that person, how often they 
spoke with the friend or relative about their cancer, how much they resemble the friend or 
relative physically or in terms of personality, how often they think about the cancer 
experience and how much the experience has affected the participant. For each item, 
response options include three levels: not close or never, somewhat, or sometimes, and very 
or a lot. The three factors extracted from this scale were closeness/time spent (i.e., how close 
and how much time was spent with the affected person before and during their illness), 
resemblance (i.e., physical and personality resemblance to affected person) and time 
processing (i.e., time spent talking with the affected person about cancer, the effect of the 
cancer experience on how the participant thinks about her own health, and the time spent 
talking with friends or relatives about cancer experience). Psychometric data on the scale 
from this study sample have been reported previously [19].
Bereavement—A significant component of the cancer experience is bereavement. 
Witnessing the difficult course of a disease and death of a close relative from cancer may be 
particularly salient in the development of a woman’s sense of vulnerability to cancer and her 
worry about cancer. Women who have had a close relative die of cancer are more worried or 
distressed about cancer than those whose relatives survived [30] and breast cancer death in 
the family has been shown to be a strong predictor of medical decision-making behaviors 
[31]. Our survey participants were asked if the relative or friend with cancer that they 
identified was still living (yes/no). This question was not specific to cause of death although 
the majority were cancer deaths.
Ovarian cancer knowledge—Women’s general knowledge about ovarian cancer can 
influence the cognitive assessment of their perceived risk. To assess knowledge, participants 
were asked whether seven factors increase, decrease, or have no effect on a woman’s 
chances of getting ovarian cancer. These included: being hit in the abdomen; having one or 
more close relatives with ovarian cancer; giving birth; having breast, colorectal or 
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endometrial cancer; getting older; having many sexual partners; and taking oral 
contraceptives. Participants were also asked whether they believed that women with ovarian 
cancer never experience symptoms and whether ovarian cancer causes more deaths than 
breast cancer. Correct answers were summed across the items for a total knowledge score.
Cancer cause—To operationalize how women have formulated their own cognitive 
models of inheritance, they were asked to give an open-ended response to what they think 
might increase their own chances of getting cancer. Answers were dichotomized into family 
history/genetic causes versus all other causes.
Seriousness of cancer—The perceived seriousness of an illness might influence a 
women’s sense of vulnerability to that illness. Women were asked how much they agreed or 
disagreed with the statement, ‘Getting ovarian cancer would be a serious problem.’ 
Response options included strongly agree, agree, disagree, or strongly disagree.
Demographics—Several studies have shown that older women report lower levels of 
perceived risk of cancer than younger women, so age was included as a potential 
determinant of perceived risk [32,33]. We excluded women younger than 30 years of age 
because both ovarian cancer risk and the likelihood of experiencing cancer among family 
members and friends were lower for women 29 years of age and younger.
Statistical analysis
Means, standard deviations, and intercorrelations were computed for all study variables. In 
addition, all variables were checked for normality and presence of outliers.
Path model analysis—Following our conceptual model [20,21], we used path analysis to 
quantify direct and indirect pathways through which the salience of the cancer experience 
(time spent with affected person, bereavement, and observation of change in the affected 
person’s quality of life) leads to the emotional processing of the experience (time spent 
thinking/speaking about the cancer experience), which, in turn, are hypothesized to 
influence a personal sense of vulnerability (perceived risk). Other variables directly 
influencing perceived risk were ovarian cancer knowledge, the number of relatives with 
ovarian cancer, age of the respondent, the number of relatives with any cancer, and belief in 
a genetic cause of cancer in the affected person. Model fit was assessed with several fit 
indices: most importantly, the CFI, the RMSEA, and the NFI. RMSEA values at or above 
0.10 indicate a poorly fitting model with values between 0.05 and 0.09, indicating an 
average fit and values below 0.05 indicating a very good fit. Well-fitting models have a CFI 
value approaching 1.0 (>0.90) and a NFI value >0.90 [34].
Analyses were carried out with EQS Version 6. The default estimation method typically 
used in path analyses is maximum likelihood—a method that assumes normality of 
variables. As several of our variables violated this assumption, we used a robust maximum 
likelihood estimation procedure [35].
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Of the 2524 women who completed the CATI interview, 250 did not have a close relative or 
friend with cancer and 101 chose not to reveal whether they could identify such a person. 
We deleted 162 additional observations with missing or do not know values on the variables 
of interest, leaving a total of 2011 observations for our analysis. Participants ranged in age 
from 30 to 77 years with an average age of 55 years. The majority were-non-Hispanic white 
(68%), had some college education (63%), were married (67%), and reported a relatively 
high annual income (61% with income at least $50 000).
Table 1 displays the means, standard deviations, and Pearson correlation coefficients among 
the 14 variables used in the path model. Most variables did not exhibit extreme skewness 
(>2) or extreme kurtosis (.7) Cancer worry and number of ovarian cancer relatives had the 
highest skewness values of 2.1 and 1.7, respectively. The seriousness variable was excluded 
from further analyses because 96% of respondents endorsed the seriousness of ovarian 
cancer. Perceived risk was most strongly correlated with number of relatives with cancer 
and cancer worry. Closeness/time spent was positively correlated with time spent processing 
the cancer experience and state anxiety was correlated with trait anxiety. Bereavement (the 
close person was alive) was negatively associated with observing a negative change in 
quality of life.
Our initial path model in which time spent processing the cancer experience, worry, and the 
other covariates led directly to perceived risk achieved an average fit (RMSEA = 0.06 and 
CFI = 0.94). We conducted an exploratory investigation that separated the emotional from 
the cognitive aspects of perceived risk by creating a path from the closeness/time spent 
through time processing to worry and then to perceived risk. We believe this modification 
more closely aligns with hypotheses about the dual nature of judgments such as perceived 
risk, in addition to suggesting how emotional processes are integrated into risk perceptions. 
In this model, we classified resemblance as part of the cancer experience that predicted time 
spent processing. This path model was a very good fit to the data (CFI = 0.99; RMSEA = 
0.028 [0.017, 0.036]; NFI = 0.98), and all path coefficients were statistically significant 
(Figure 2). Overall, the model accounted for 23% of the variability (r-squared) in perceived 
risk. Because of the satisfactory model fit and the conceptual interpretability of the model, 
we elected not to make any further modifications.
Although the path coefficients for resemblance and bereavement were statistically 
significant, the strongest predictors of time processing were time spent with the affected 
person and observation of negative change in that person. Higher scores on time processing 
the cancer experience, state anxiety, and the number of ovarian cancer relatives were all 
positively associated with worry. Although statistically significant, the path coefficient for 
time processing to perceived risk was small. Worry, in turn, strongly predicted perceived 
risk as did the number of relatives with ovarian cancer. The cognitive components of 
perceived risk (i.e., the number of relatives with cancer, a higher cancer knowledge score, 
and a belief in the genetic causes of cancer) positively predicted perceived risk. As would be 
expected from the literature, age was negatively associated with perceived risk.
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Our results describe how the emotional experience of cancer as lived through an affected 
person can exert a strong influence on a person’s cancer worry and subsequently on their 
sense of vulnerability to cancer. We framed our analysis on a conceptual model that 
incorporated the cancer experience and processing of that experience as a guide to 
understanding how perceived risk is constructed, and modified our initial path model to 
attempt to discriminate between the emotional and cognitive antecedents. The direct effects 
of worry and the number of relatives with ovarian cancer on perceived risk were the 
strongest predictors in the final model.
Perceived risk is elicited as a response to questions about numeric risk or comparative risk 
and it is important to recognize that a woman’s response to a risk perception question will 
incorporate her cancer experiences. The model presented here suggests that it is important 
and reasonable to think of the emotional component of perceived risk as an ‘affectively 
charged evaluative reaction’ to a question that incorporates both a person’s experience and 
cognitive understanding [36]. Our model is also consistent with the concept that affect and 
cognition are inextricably linked, and that focusing solely on cognitive and objective 
information might not be successful in risk communication. A recent intervention study of 
tailored breast cancer risk communication found that after receiving such information, 
women not only misreported their risk scores, but also tended to believe that the risk scores 
did not adequately capture their cancer family history background. This occurred despite the 
heavy reliance of family history in the construction of risk scores [37]. If risk scores are 
typically calculated by number and type of relative and age at diagnosis, clearly something 
about the experience of cancer in the family will not be captured. It is also important to 
recognize that the concepts of risk, chance, and likelihood are challenging for both lay 
people and professionals. A recent study of individuals in a low-income community found 
that 49% and 63% of respondents who were asked about their ‘perceived chance’ and 
‘perceived likelihood’ of developing colorectal cancer chose ‘don’t know’ when explicitly 
given that choice [38].
Perspectives from the field of judgment and decision making [14] and from models that 
describe how both cognitive and emotional processes are involved in risk construction and 
in regulation of health threats [21] guided the selection of measures and instruments in the 
current study. We developed measures that attempted to capture the emotional components 
of perceived risk—specifically those related to women’s experience of cancer among friends 
or relatives—which allowed us to examine the connection between emotional processes and 
perceived risk. We were able to conduct this survey in a large, racially-diverse managed care 
population, which is a strength because much of the research on genetic risk and counseling 
has been conducted among women attending specialized health clinics or recruited from 
family members of women at high risk who are likely to differ from women in community 
settings with respect to perceived risk and family history of cancer [39]. Our population 
provided a reasonable compromise between a general population-based survey and a clinic-
based survey.
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We note several limitations. Family history was self-reported. Although reporting of first-
degree relatives is generally considered reliable, some studies have described an under-
reporting of ovarian cancer in relatives, especially second-degree relatives [27]. Another 
potential limitation is the modest reliability of some of the measures in this study because of 
fewer response options. The three response categories for the questions in the Connection to 
the Experience of Cancer Scale was motivated by a preference for fewer categories in 
cognitive testing and to reduce response burden. Our data were cross-sectional in nature, 
which limited our ability to make inferences about causal attributes. Finally, although our 
sample was racially diverse, it represented one health plan in one area of the country and 
may not be generalizable to vastly different populations.
Elucidating the relationship between cancer experiences among relatives and friends and 
cancer worry adds to our knowledge about how individuals perceive their vulnerability to 
cancer. Developing the methods to effectively measure, solicit, and use this information can 
help us construct more effective risk communications. Furthermore, explicitly recognizing 
the importance of the cancer experience among relatives or friends can help identify women 
who might be especially prone to distress regarding cancer and who might benefit from 
additional counseling. Finally, with rapid growth in genetic and molecular medicine, 
information on personal susceptibility to a host of diseases is increasingly available to 
individuals who want to avoid or reduce potential health problems.
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Conceptual model of perceived risk and cancer
* affect, availability and representativeness heuristics
Adapted from Walter et al., 2004; Walter and Emery 2005
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Path analytic model of time processing, worry, and perceived risk for 2011 study 
participants showing standardized path coefficients
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